Special Interest Papers for ACC Cardiologists

Citations 1-10 of 10 total displayed.

Most recent content (1 Feb 2009):

Mini-Review
The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines

Samia Mora, Kiran Musunuru, and Roger S. Blumenthal
Clin. Chem. 2009; 55: 219-228. [Abstract] [Full text] [PDF]  

Proteomics and Protein Markers
Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular Death

Benjamin M. Scirica, Christopher P. Cannon, Marc S. Sabatine, Petr Jarolim, Sarah Sloane, Nader Rifai, Eugene Braunwald, David A. Morrow for the PROVE IT–TIMI 22 Investigators
Clin. Chem. 2009; 55: 265-273. [Abstract] [Full text] [PDF]  

Proteomics and Protein Markers
Lipopolysaccharide-Binding Protein: A New Biomarker for Infectious Endocarditis?

Tanja Vollmer, Cornelia Piper, Knut Kleesiek, and Jens Dreier
Clin. Chem. 2009; 55: 295-304. [Abstract] [Full text] [PDF]  

Preamble
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Emerging Biomarkers for Primary Prevention of Cardiovascular Disease

NACB LMPG Committee Members, Gary L. Myers, Robert H.M. Christenson, Mary Cushman, Christie M. Ballantyne, Gerald R. Cooper, Christine M. Pfeiffer, Scott M. Grundy, Darwin R. Labarthe, Daniel Levy, Nader Rifai, and Peter W.F. Wilson
Clin. Chem. 2009; 55: 378-384. [Abstract] [Full text] [PDF]  

Past content (since Dec 2008):

Editorials
Evaluation of High-Sensitivity Assays for Cardiac Troponin

David A. Morrow and Elliott M. Antman
Clin. Chem. 2009; 55: 5-8. [Extract] [Full text] [PDF]  

Editorials
Novel Biomarkers of Cardiovascular Disease: Myeloperoxidase for Acute and/or Chronic Heart Failure?

Alan H.B. Wu
Clin. Chem. 2009; 55: 12-14. [Extract] [Full text] [PDF]  

Perspectives
The Spin Stops Here: Inhibition of Lipoprotein-Associated Phospholipase A2— A Promising Target but a Negative Initial Trial?

Joseph P. McConnell and Allan S. Jaffe
Clin. Chem. 2009; 55: 21-23. [Extract] [Full text] [PDF]  

Proteomics and Protein Markers
Short- and Long-Term Biological Variation in Cardiac Troponin I Measured with a High-Sensitivity Assay: Implications for Clinical Practice

Alan H.B. Wu, Quynh Anh Lu, John Todd, Joachim Moecks, and Frank Wians
Clin. Chem. 2009; 55: 52-58. [Abstract] [Full text] [PDF]  

Proteomics and Protein Markers
Lack of Diagnostic and Prognostic Utility of Circulating Plasma Myeloperoxidase Concentrations in Patients Presenting with Dyspnea

Keyur B. Shah, Willem J. Kop, Robert H. Christenson, Deborah B. Diercks, Dick Kuo, Sue Henderson, Karen Hanson, Mandeep R. Mehra, and Christopher R. deFilippi
Clin. Chem. 2009; 55: 59-67. [Abstract] [Full text] [PDF]  

Lipids, Lipoproteins, and Cardiovascular Risk Factors
Association of Lipoprotein-Associated Phospholipase A₂ Mass and Activity with Coronary and Aortic Atherosclerosis: Findings from the Dallas Heart Study

Emmanouil S. Brilakis, Amit Khera, Bilal Saeed, Subhash Banerjee, Darren K. McGuire, Sabina A. Murphy, and James A. de Lemos
Clin. Chem. 2008; 54: 1975-1981. [Abstract] [Full text] [PDF]